REGENXBIO Inc.·4

May 30, 4:35 PM ET

Tasse Daniel 4

4 · REGENXBIO Inc. · Filed May 30, 2018

Insider Transaction Report

Form 4
Period: 2018-05-25
Tasse Daniel
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-05-25+12,50012,500 total
    Exercise: $49.45Exp: 2028-05-25Common Stock (12,500 underlying)
Footnotes (1)
  • [F1]The option will vest in 12 equal monthly installments following May 25, 2018.

Documents

2 files
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POA - DANIEL TASSE